Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Cervical Cancer

  Free Subscription


1 Acta Obstet Gynecol Scand
1 Am J Clin Pathol
2 Arch Gynecol Obstet
1 Asian J Surg
3 Asian Pac J Cancer Prev
1 Bioorg Med Chem Lett
1 BMC Bioinformatics
1 BMC Health Serv Res
1 BMC Palliat Care
1 BMC Public Health
1 BMC Womens Health
2 BMJ Open
2 Br J Gen Pract
1 Brachytherapy
1 Cancer
1 Cancer Epidemiol Biomarkers Prev
1 Clin Anat
1 Clin Transl Gastroenterol
1 Clinics (Sao Paulo)
1 Comput Math Methods Med
1 Cytojournal
2 Diagn Cytopathol
1 Ecancermedicalscience
1 Eur J Cancer
1 Front Cell Infect Microbiol
2 Front Immunol
1 Front Neurol
4 Front Oncol
1 Front Public Health
1 Genet Res (Camb)
3 Gynecol Oncol
1 Inflamm Bowel Dis
1 Int J Cancer
1 Int J Gen Med
1 Int J Mol Sci
1 Int J Womens Health
1 J Am Assoc Nurse Pract
1 J Cancer Res Clin Oncol
2 J Cancer Res Ther
1 J Healthc Eng
1 J Med Imaging Radiat Oncol
2 J Obstet Gynaecol India
1 J Obstet Gynaecol Res
1 J Oncol
1 J Oncol Pharm Pract
1 J Robot Surg
1 J Trace Elem Med Biol
1 Jpn J Clin Oncol
1 Lancet Oncol
1 Lymphat Res Biol
1 Magn Reson Imaging
1 Med Dosim
1 Minerva Med
1 Nanoscale
1 Oncol Rep
3 PLoS One
2 Reprod Sci
2 Sci Rep
1 Sensors (Basel)
1 Updates Surg
2 Virol J

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Obstet Gynecol Scand

  1. PENG H, He X, Wang Q
    Immune checkpoint blockades in gynecological cancers: A review of clinical trials.
    Acta Obstet Gynecol Scand. 2022 Jun 25. doi: 10.1111/aogs.14412.
    PubMed         Abstract available

    Am J Clin Pathol

  2. GOYAL A, Heymann JJ, Alperstein SA, Siddiqui MT, et al
    Underrecognized Patterns of High-Grade Squamous Intraepithelial Lesion on ThinPrep Preparations.
    Am J Clin Pathol. 2022;158:315.

    Arch Gynecol Obstet

  3. CANPOLAT M, Birge O, Danisman T, Uncu YA, et al
    The detection of cervical neoplasia via optical imaging: a pilot clinical study.
    Arch Gynecol Obstet. 2022;306:433-441.
    PubMed         Abstract available

  4. KAMPERS J, Gerhardt E, Sibbertsen P, Flock T, et al
    Perioperative morbidity of different operative approaches in early cervical carcinoma: a systematic review and meta-analysis comparing minimally invasive versus open radical hysterectomy.
    Arch Gynecol Obstet. 2022;306:295-314.
    PubMed         Abstract available

    Asian J Surg

  5. LIU Y, Kuang L, He Y, Wang X, et al
    An accidentally found metastatic cervical cancer for three years after loop electrosurgical excision procedure treatment for cervical intraepithelial neoplasia 3.
    Asian J Surg. 2022 Jul 30. pii: S1015-9584(22)00933.

    Asian Pac J Cancer Prev

  6. TASKIN MH, Nursal AF, Oruc MA, Kariptas E, et al
    Genotype Distribution and Prevalence of High-Risk Human Papillomavirus Infection among Women in Samsun Province of Turkey.
    Asian Pac J Cancer Prev. 2022;23:2477-2482.
    PubMed         Abstract available

  7. SUWIWAT S, Tungsinmunlong K, Siriaungkul S
    Expression of CD44v6 and RCAS1 in Uterine Cervical Carcinoma Infected with Human Papillomavirus and Its Effect on Cell Proliferation and Differentiation.
    Asian Pac J Cancer Prev. 2022;23:2431-2439.
    PubMed         Abstract available

  8. FIRDAUS MER, Mustopa AZ, Triratna L, Syahputra G, et al
    Dissection of Capsid Protein HPV 52 to Rationalize Vaccine Designs Using Computational Approaches Immunoinformatics and Molecular Docking.
    Asian Pac J Cancer Prev. 2022;23:2243-2253.
    PubMed         Abstract available

    Bioorg Med Chem Lett

  9. SUN J, Jin R
    PFKFB4 modulated by miR-195-5p can boost the malignant progression of cervical cancer cells.
    Bioorg Med Chem Lett. 2022 Aug 1:128916. doi: 10.1016/j.bmcl.2022.128916.
    PubMed         Abstract available

    BMC Bioinformatics

  10. SANAMI S, Rafieian-Kopaei M, Dehkordi KA, Pazoki-Toroudi H, et al
    In silico design of a multi-epitope vaccine against HPV16/18.
    BMC Bioinformatics. 2022;23:311.
    PubMed         Abstract available

    BMC Health Serv Res

  11. AMMOUN R, Wami WM, Otieno P, Schultsz C, et al
    Readiness of health facilities to deliver non-communicable diseases services in Kenya: a national cross-sectional survey.
    BMC Health Serv Res. 2022;22:985.
    PubMed         Abstract available

    BMC Palliat Care

  12. KEBEBEW T, Mosalo A, Mavhandu-Mudzusi AH
    Hospital-based evaluation of palliative care among patients with advanced cervical cancer: a cross-sectional study.
    BMC Palliat Care. 2022;21:140.
    PubMed         Abstract available

    BMC Public Health

  13. OSEI EA, Appiah S, Oti-Boadi E, Hammond D, et al
    Experiences of women awaiting cervical CANCER screening results from selected hospitals in Accra, Ghana.
    BMC Public Health. 2022;22:1467.
    PubMed         Abstract available

    BMC Womens Health

  14. ARSLAN HN, Oruc MA
    Results from a cervical cancer screening program in Samsun, Turkey.
    BMC Womens Health. 2022;22:331.
    PubMed         Abstract available


  15. KECHAGIAS KS, Kalliala I, Bowden SJ, Athanasiou A, et al
    Role of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: systematic review and meta-analysis.
    BMJ. 2022;378:e070135.
    PubMed         Abstract available

    BMJ Open

  16. OKYERE J, Aboagye RG, Seidu AA, Asare BY, et al
    Towards a cervical cancer-free future: women's healthcare decision making and cervical cancer screening uptake in sub-Saharan Africa.
    BMJ Open. 2022;12:e058026.
    PubMed         Abstract available

  17. HU C, Xu Y, Zhang Q, Liu Q, et al
    Does completion of radical hysterectomy improve oncological outcomes of women with clinical early-stage cervical cancer and intraoperative detection of nodal involvement?: protocol for a systematic review and meta-analysis.
    BMJ Open. 2022;12:e056848.
    PubMed         Abstract available

    Br J Gen Pract

  18. LANDY R, Hollingworth T, Waller J, Marlow LA, et al
    Non-speculum clinician-taken samples for human papillomavirus testing: a cross-sectional study in older women.
    Br J Gen Pract. 2022;72:e538-e545.
    PubMed         Abstract available

  19. DAVIES-OLIVEIRA JC, Round T, Crosbie EJ
    Cervical screening: the evolving landscape.
    Br J Gen Pract. 2022;72:364-365.


  20. AOSHIKA T, Noda SE, Abe T, Kumazaki Y, et al
    Results of computer tomography-based adaptive brachytherapy in combination with whole-pelvic- and central-shielding-external beam radiotherapy for cervical cancer.
    Brachytherapy. 2022 Aug 1. pii: S1538-4721(22)00116.
    PubMed         Abstract available


  21. MCDANIELS-DAVIDSON C, Feng CH, Martinez ME, Canchola AJ, et al
    Improved survival in cervical cancer patients receiving care at National Cancer Institute-designated cancer centers.
    Cancer. 2022 Aug 2. doi: 10.1002/cncr.34404.
    PubMed         Abstract available

    Cancer Epidemiol Biomarkers Prev

  22. BUKOWSKI A, Hoyo C, Hudgens MG, Brewster WR, et al
    Extended Human Papillomavirus Genotyping to Predict Progression to High-Grade Cervical Precancer: A Prospective Cohort Study in the Southeastern United States.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1564-1571.
    PubMed         Abstract available

    Clin Anat

  23. AKSAKAL SE, Pay RE, Kose C, Altinbas SK, et al
    The effect of anterior uterocervical angle and cervical length on the development of pelvic inflammatory disease.
    Clin Anat. 2022;35:732-737.
    PubMed         Abstract available

    Clin Transl Gastroenterol

  24. MANN S, Jess T, Allin K, Elmahdi R, et al
    Risk of Cervical Cancer in Inflammatory Bowel Disease: A Meta-Analysis of Population-Based Studies.
    Clin Transl Gastroenterol. 2022;13:e00513.
    PubMed         Abstract available

    Clinics (Sao Paulo)

  25. CASAS CPR, Albuquerque RCR, Loureiro RB, Gollner AM, et al
    Cervical cancer screening in low- and middle-income countries: A systematic review of economic evaluation studies.
    Clinics (Sao Paulo). 2022;77:100080.
    PubMed         Abstract available

    Comput Math Methods Med

  26. ZHANG J, Wang K
    Mathematical Modeling and Computational Prediction of High-Risk Types of Human Papillomaviruses.
    Comput Math Methods Med. 2022;2022:1515810.
    PubMed         Abstract available


    Role of immunocytochemistry in cervical cancer screening.
    Cytojournal. 2022;19:42.
    PubMed         Abstract available

    Diagn Cytopathol

  28. CHO S, Lee SM, Lee S, Cho HW, et al
    The necessity of continuing cervical cancer screening of elderly Korean women aged 65 years or older.
    Diagn Cytopathol. 2022 Jul 30. doi: 10.1002/dc.25021.
    PubMed         Abstract available

  29. ZHANG L, Qi R, Wang L, Jiang F, et al
    Clinical value of the ThinPrep cytologic test with E6/E7 mRNA detection for cervical cancer screening in disease diagnosis.
    Diagn Cytopathol. 2022 Aug 1. doi: 10.1002/dc.25025.
    PubMed         Abstract available


    Cues to cervical cancer screening and reaction to cervical cancer diagnosis during screening among women in Shai Osudoku District, Ghana.
    Ecancermedicalscience. 2022;16:1392.
    PubMed         Abstract available

    Eur J Cancer

  31. OAKNIN A, Monk BJ, Vergote I, Cristina de Melo A, et al
    EMPOWER CERVICAL-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer.
    Eur J Cancer. 2022 Jul 31. pii: S0959-8049(22)00160.
    PubMed         Abstract available

    Front Cell Infect Microbiol

  32. LU J, Li Y, Wang J
    Small Cell (Neuroendocrine) Carcinoma of the Cervix: An Analysis for 19 Cases and Literature Review.
    Front Cell Infect Microbiol. 2022;12:916506.
    PubMed         Abstract available

    Front Immunol

  33. XU HH, Wang HL, Xing TJ, Wang XQ, et al
    A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
    Front Immunol. 2022;13:851622.
    PubMed         Abstract available

  34. ZHANG J, Meng S, Zhang X, Shao K, et al
    Infiltration Patterns of Cervical Epithelial Microenvironment Cells During Carcinogenesis.
    Front Immunol. 2022;13:888176.
    PubMed         Abstract available

    Front Neurol

  35. ZHENG X, Xu S, Wu J
    Cervical Cancer Imaging Features Associated With ADRB1 as a Risk Factor for Cerebral Neurovascular Metastases.
    Front Neurol. 2022;13:905761.
    PubMed         Abstract available

    Front Oncol

  36. OLTEAN T, Lippens L, Lemeire K, De Tender C, et al
    Association of Cell Death Markers With Tumor Immune Cell Infiltrates After Chemo-Radiation in Cervical Cancer.
    Front Oncol. 2022;12:892813.
    PubMed         Abstract available

  37. LI Y, Qu J, Liu L, Sun Y, et al
    Apogossypolone Inhibits Cell Proliferation and Epithelial-Mesenchymal Transition in Cervical Cancer via Activating DKK3.
    Front Oncol. 2022;12:948023.
    PubMed         Abstract available

  38. SUN C, Wang S, Ye W, Wang R, et al
    The Prognostic Value of Tumor Size, Volume and Tumor Volume Reduction Rate During Concurrent Chemoradiotherapy in Patients With Cervical Cancer.
    Front Oncol. 2022;12:934110.
    PubMed         Abstract available

  39. REN X, Fu Y, Liu Z, Lin X, et al
    Image-guided interstitial brachytherapy for recurrent cervical cancer after radiotherapy: A single institution experience.
    Front Oncol. 2022;12:943703.
    PubMed         Abstract available

    Front Public Health

  40. TEUFEL-SHONE NI, Goldtooth-Begay C, Begay AB, Lazaro A, et al
    Maintaining the Partnership Between a Tribal Breast and Cervical Cancer Program and a University-Based Cancer Prevention Center During COVID-19 Lock-Down Restrictions-A Case Study.
    Front Public Health. 2022;10:902253.
    PubMed         Abstract available

    Genet Res (Camb)

  41. DIAKITE B, Kassogue Y, Maiga M, Dolo G, et al
    Association of the Interleukin-10-592C/A Polymorphism and Cervical Cancer Risk: A Meta-Analysis.
    Genet Res (Camb). 2022;2022:2319161.
    PubMed         Abstract available

    Gynecol Oncol

  42. BOGANI G, Donato VD, Scambia G, Landoni F, et al
    Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer.
    Gynecol Oncol. 2022 Jul 28. pii: S0090-8258(22)00494.
    PubMed         Abstract available

  43. SIVARS L, Hellman K, Crona Guterstam Y, Holzhauser S, et al
    Circulating cell-free tumor human papillomavirus DNA is a promising biomarker in cervical cancer.
    Gynecol Oncol. 2022 Jul 30. pii: S0090-8258(22)00512.
    PubMed         Abstract available

  44. ALHOLM Z, He D, Ting J, Zhang YJ, et al
    Real-world treatment drop-off among recurrent or metastatic cervical cancer patients: A US community oncology-based analysis.
    Gynecol Oncol. 2022 Jul 29. pii: S0090-8258(22)00509.
    PubMed         Abstract available

    Inflamm Bowel Dis

  45. YU N, Basnayake C, Connell W, Ding NS, et al
    Interventions to Improve Adherence to Preventive Care in Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2021 Oct 7. pii: 6383125. doi: 10.1093.
    PubMed         Abstract available

    Int J Cancer

  46. JOSHI S, Muwonge R, Kulkarni V, Mandolkar M, et al
    Can we increase the cervical cancer screening interval with an HPV test for women living with HIV? Results of a cohort study from Maharashtra, India.
    Int J Cancer. 2022 Jul 19. doi: 10.1002/ijc.34221.
    PubMed         Abstract available

    Int J Gen Med

  47. XU J, Ma Y, Mei H, Wang Q, et al
    Diagnostic Value of Multimodal Magnetic Resonance Imaging in Discriminating Between Metastatic and Non-Metastatic Pelvic Lymph Nodes in Cervical Cancer.
    Int J Gen Med. 2022;15:6279-6288.
    PubMed         Abstract available

    Int J Mol Sci

  48. SHEN-GUNTHER J, Cai H, Wang Y
    HPV Integration Site Mapping: A Rapid Method of Viral Integration Site (VIS) Analysis and Visualization Using Automated Workflows in CLC Microbial Genomics.
    Int J Mol Sci. 2022;23.
    PubMed         Abstract available

    Int J Womens Health

  49. ZHAO F, Ma D, Wang T, Zhang Y, et al
    The Application of Liquid-Based Cytological Detection for P16, Cytologic Evaluation and High-Risk Human Papillomavirus Testing in Cervical Cancer Screening: A Clinical Evaluation.
    Int J Womens Health. 2022;14:965-973.
    PubMed         Abstract available

    J Am Assoc Nurse Pract

    Implementing a standardized protocol to improve cervical cancer screening rates in primary care.
    J Am Assoc Nurse Pract. 2022 Jul 29. pii: 01741002-990000000-00036.
    PubMed         Abstract available

    J Cancer Res Clin Oncol

  51. GULER OC, Onal C
    Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo)radiotherapy: a systematic review and metaanalysis. In regard to De Virgilio et al.
    J Cancer Res Clin Oncol. 2022;148:2567-2568.
    PubMed         Abstract available

    J Cancer Res Ther

  52. VERMA ML, Singh U, Kumari R, Sachan R, et al
    Randomized controlled study for comparison of efficacy and safety between thermocoagulation and cryotherapy in visual inspection with acetic acid positive cervical lesions.
    J Cancer Res Ther. 2022;18:603-611.
    PubMed         Abstract available

  53. GADDA IR, Khan NA, Wani SQ, Baba MH, et al
    To evaluate the use of tandem and cylinder as an intracavitary brachytherapy device for carcinoma of the cervix with regard to local control and toxicities.
    J Cancer Res Ther. 2022;18:740-746.
    PubMed         Abstract available

    J Healthc Eng

  54. HE L, Wang Z, Chen J, Chen L, et al
    Analysis of Clinicopathological Factors Associated with Radiation-Induced Cystitis in Patients with Cervical Cancer.
    J Healthc Eng. 2022;2022:6216072.
    PubMed         Abstract available

    J Med Imaging Radiat Oncol

  55. MOHAMMED KE, Nagar T, Pearson SM, Donaldson J, et al
    Dosimetric comparison of high-dose rate cervix brachytherapy with and without interstitial needles and the impact on target volume coverage, and organ at risk constraints.
    J Med Imaging Radiat Oncol. 2022;66:671-677.
    PubMed         Abstract available

    J Obstet Gynaecol India

  56. BHARDWAJ R, Boruah DK, Gogoi BB, Zahir F, et al
    Added-Value of Diffusion-Weighted Imaging (DWI) and Dynamic Contrast-Enhanced (DCE-MRI) Magnetic Resonance Imaging in the Preoperative Assessment of Cervical Cancer.
    J Obstet Gynaecol India. 2022;72:330-340.
    PubMed         Abstract available

  57. GARG S, Shekhawat U, Vohra R, Gupta R, et al
    Pretreatment Immune Status, Predicts Response to Definite Chemo Radiotherapy in Advanced Stages of Cervical Cancer Patients.
    J Obstet Gynaecol India. 2022;72.
    PubMed         Abstract available

    J Obstet Gynaecol Res

  58. JASPER B, Thorley E, Martins FC, Haldar K, et al
    The incidence of cervical cancer in women with postcoital bleeding and abnormal appearance of the cervix referred through the 2-week wait pathway in the United Kingdom: A retrospective cohort study.
    J Obstet Gynaecol Res. 2022 Jul 30. doi: 10.1111/jog.15366.
    PubMed         Abstract available

    J Oncol

  59. SU B, Zhong M, Zhang Y, Wu K, et al
    Deficiency of kin17 Facilitates Apoptosis of Cervical Cancer Cells by Modulating Caspase 3, PARP, and Bcl-2 Family Proteins.
    J Oncol. 2022;2022:3156968.
    PubMed         Abstract available

    J Oncol Pharm Pract

  60. ISAAKA J, Degu A, Kimani LM
    Assessment of cisplatin-induced nephrotoxicity and its associated factors among cervical cancer patients in the leading tertiary hospital in Kenya.
    J Oncol Pharm Pract. 2022 Aug 5:10781552221119417.
    PubMed         Abstract available

    J Robot Surg

  61. LING H, Wang G, Yi B, Li Z, et al
    Clavien-Dindo classification and risk prediction model of complications after robot-assisted radical hysterectomy for cervical cancer.
    J Robot Surg. 2022 Aug 1. pii: 10.1007/s11701-022-01450.
    PubMed         Abstract available

    J Trace Elem Med Biol

  62. QI L, Zhou H, Wang Y, Jablonska E, et al
    The role of selenoprotein P in the determining the sensitivity of cervical cancer patients to concurrent chemoradiotherapy: A metabonomics-based analysis.
    J Trace Elem Med Biol. 2022;73:127041.
    PubMed         Abstract available

    Jpn J Clin Oncol

  63. SHIBUYA Y, Shimada M, Tsuji K, Shigeta S, et al
    Prognostic factors of 2018 FIGO stage IB-IIA cervical cancer with absence of high/ intermediate surgical-pathological risk factors.
    Jpn J Clin Oncol. 2022 Aug 1. pii: 6652791. doi: 10.1093.
    PubMed         Abstract available

    Lancet Oncol

  64. SEKINE M, Yamaguchi M, Kudo R, Hanley SJB, et al
    Problems with catch-up HPV vaccination after resumption of proactive recommendations.
    Lancet Oncol. 2022;23:972-973.

    Lymphat Res Biol

  65. LIU G, Hu J, Liu Y, Yuan M, et al
    Factors Influencing Lower Limb Lymphedema After Cervical Cancer Surgery: A Case-Control Study.
    Lymphat Res Biol. 2022 Jul 29. doi: 10.1089/lrb.2022.0025.
    PubMed         Abstract available


  66. CIRIS P
    Information theoretic evaluation of Lorentzian, Gaussian, Voigt, and symmetric alpha-stable models of reversible transverse relaxation in cervical cancer in vivo at 3 T.
    MAGMA. 2022 Aug 4. pii: 10.1007/s10334-022-01035.
    PubMed         Abstract available

    Magn Reson Imaging

  67. WANG S, Jiang T, Hu X, Hu H, et al
    Can the combination of DWI and T2WI radiomics improve the diagnostic efficiency of cervical squamous cell carcinoma?
    Magn Reson Imaging. 2022;92:197-202.
    PubMed         Abstract available

    Med Dosim

  68. KATO T, Ono T, Narita Y, Komori S, et al
    Dose-volume comparison of intensity modulated proton therapy and volumetric modulated arc therapy for cervical esophageal cancer.
    Med Dosim. 2022;47:216-221.
    PubMed         Abstract available

    Minerva Med

  69. YE L, Jiang J, Fang Y, Cao C, et al
    Study on the clinical significance of cervical conization under the guidance of colposcopy in the treatment of cervical lesions.
    Minerva Med. 2022;113:745-748.


  70. PRASAD A, Khatua A, Mohanta YK, Saravanan M, et al
    Low-dose exposure to phytosynthesized gold nanoparticles combined with glutamine deprivation enhances cell death in the cancer cell line HeLa via oxidative stress-mediated mitochondrial dysfunction and G0/G1 cell cycle arrest.
    Nanoscale. 2022;14:10399-10417.
    PubMed         Abstract available

    Oncol Rep

  71. LIU C, Feng H, Song L, Li S, et al
    Synergistic effects of thalidomide and cisplatin are mediated via the PI3K/AKT and JAK1/STAT3 signaling pathways in cervical cancer.
    Oncol Rep. 2022;48.
    PubMed         Abstract available

    PLoS One

  72. CORREA RM, Baena A, Valls J, Colucci MC, et al
    Distribution of human papillomavirus genotypes by severity of cervical lesions in HPV screened positive women from the ESTAMPA study in Latin America.
    PLoS One. 2022;17:e0272205.
    PubMed         Abstract available

  73. FRIEBEL-KLINGNER TM, Iyer HS, Ramogola-Masire D, Bazzett-Matabele L, et al
    Evaluating the geographic distribution of cervical cancer patients presenting to a multidisciplinary gynecologic oncology clinic in Gaborone, Botswana.
    PLoS One. 2022;17:e0271679.
    PubMed         Abstract available

  74. LIU SS, Chan KKL, Wei TN, Tse KY, et al
    Clinical performance of the Roche Cobas 4800 HPV test for primary cervical cancer screening in a Chinese population.
    PLoS One. 2022;17:e0272721.
    PubMed         Abstract available

    Reprod Sci

  75. YU M, Xue S, Chen X, Wu K, et al
    Long Non-coding RNA UCA1a Promotes Proliferation via PKM2 in Cervical Cancer.
    Reprod Sci. 2022 Aug 4. pii: 10.1007/s43032-022-01042.
    PubMed         Abstract available

  76. LIU Y, Mei L, Chen Y, Zhang X, et al
    Association Between Potentially Functional Variants in chr5q14 and the Risk of Cervical Cancer in a Chinese Population.
    Reprod Sci. 2022 Jul 18. pii: 10.1007/s43032-022-01032.
    PubMed         Abstract available

    Sci Rep

  77. HUANG W, Xu H, Hu H, Zhang D, et al
    The prevalence of human papillomavirus among women in northern Guangdong Province of China.
    Sci Rep. 2022;12:13353.
    PubMed         Abstract available

  78. URE A, Mukhedkar D, Arroyo Muhr LS
    Using HPV-meta for human papillomavirus RNA quality detection.
    Sci Rep. 2022;12:13058.
    PubMed         Abstract available

    Sensors (Basel)

  79. AGUSTIANSYAH P, Nurmaini S, Nuranna L, Irfannuddin I, et al
    Automated Precancerous Lesion Screening Using an Instance Segmentation Technique for Improving Accuracy.
    Sensors (Basel). 2022;22.
    PubMed         Abstract available

    Updates Surg

  80. DELLA CORTE L, Mercorio A, Giampaolino P, Vitale SG, et al
    The role of endocervicoscopy in women with cervical intraepithelial neoplasia: a systematic review of the literature.
    Updates Surg. 2022;74:1239-1245.
    PubMed         Abstract available

    Virol J

  81. LI H, Xiao Z, Xing B, Wu S, et al
    Association between common vaginal and HPV infections and results of cytology test in the Zhoupu District, Shanghai City, China, from 2014 to 2019.
    Virol J. 2022;19:127.
    PubMed         Abstract available

  82. PENG P, Peng X, Jiao X, Chen N, et al
    A unique Levey-Jennings control chart used for internal quality control in human papillomavirus detection.
    Virol J. 2022;19:125.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.